BeiGene: Disclosure of Share Changes and Options Interest Situation for July 2026

BeiGene announced that as of July 31, 2026, the company's statutory/registered capital is $231,100, the total issued ordinary shares are 1,426 million shares, and the treasury shares are 0 shares. During this month, the fifth amended and restated 2016 options and incentive plan had a decrease of 211,700 shares in stock options, resulting in an ending balance of 51,320,100 shares; there was no change in stock options for the sixth amended and restated 2018 employee stock purchase plan. The total amount of funds received this month from exercising options was $68,439,800.